Literature DB >> 5969361

Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.

L F Prescott, R P Buhs, J O Beattie, O C Speth, N R Trenner, L Lasagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5969361     DOI： 10.1161/01.cir.34.2.308

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Pharmacokinetics of methyldopa in healthy man.

Authors:  O Stenbaek; E Myhre; H E Rugstad; E Arnold; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

3.  Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1969-01

4.  Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).

Authors:  V Vejlsgaard; M Christensen; E Clausen
Journal:  Br Med J       Date:  1967-06-03

5.  Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.

Authors:  J A Saavedra; J L Reid; W Jordan; M D Rawlins; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of methyldopa.

Authors:  E Myhre; H E Rugstad; T Hansen
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

7.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

8.  The pharmacokinetics of alpha-methyldopa in dogs.

Authors:  G M Kochak; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

9.  A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.

Authors:  H M Jones; A J Cummings; K D Setchell; A M Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

10.  The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.

Authors:  W Y Au; L G Dring; D G Grahame-Smith; P Isaac; R T Williams
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.